Italia markets closed
FTSE MIB
33.629,21 -107,19 (-0,32%) Dow Jones
38.675,68 +450,02 (+1,18%) Nasdaq
16.156,33 +315,37 (+1,99%) Nikkei 225
38.236,07 -37,98 (-0,10%) Petrolio
77,99 -0,96 (-1,22%) Bitcoin EUR
59.080,14 +1.712,63 (+2,99%)
BMY Oct 2024 45.000 put
OPR - OPR Prezzo differito. Valuta in USD.
Aggiungi a watchlist
Alla chiusura: 12:07PM EDT
| Chiusura precedente | 3,5000 |
| Aperto | 3,6200 |
| Denaro | 3,4000 |
| Lettera | 3,5000 |
| Prezzo d'esercizio | 45,00 |
| Scadenza | 2024-10-18 |
| Min-Max giorno | 3,5000 - 3,6800 |
| Contratto - Min-Max | N/D |
| Volume | |
| Open Interest | 840 |
GlobeNewswireArbutus Appoints Two New Executives
Karen Sims, MD, PhD Promoted to Chief Medical Officer Christopher Naftzger Appointed as General Counsel and Chief Compliance Officer WARMINSTER, Pa., July 10, 2023 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq: ABUS) (“Arbutus” or the “Company”), a clinical-stage biopharmaceutical company leveraging its extensive virology expertise to develop novel therapeutics that target specific viral diseases, today announced the appointment of Dr. Karen Sims as Chief Medical Officer and Mr. Chri
© 2024 Yahoo. Tutti i diritti riservati.